← Back to All Filings

Neurocrine Biosciences Director Stephen A. Sherwin Gifts 1,000 Shares

Low SignificanceSeptember 3, 2026 at 10:20:34 PM EDT

NEUROCRINE BIOSCIENCES INC

$NBIX4CIK: 0000914475

Subscribe to track NBIX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Insider Transaction Alert: Neurocrine Biosciences Inc ($NBIX)
**Insider:** Stephen A. Sherwin (Director)
**Transaction:** Disposed / Gift (Code G)
**Shares:** 1,000 @ $0.00
**Total Value:** $0.00
**Remaining Holdings:** 14,860 shares
**Date of Transaction:** 2026-09-02
**Trading Significance:** Low (Bona fide charitable gift)

Comprehensive Analysis

Executive Summary

On September 2, 2026, Dr. Stephen A. Sherwin, a Director of Neurocrine Biosciences Inc ($NBIX), disposed of 1,000 shares of Common Stock via a bona fide gift/charitable contribution (Transaction Code G). The transaction carried no monetary consideration ($0 per share). Following this transfer, Dr. Sherwin retains direct ownership of 14,860 common shares.

Transaction Details

  • Security: Common Stock
  • Shares Transacted: 1,000 shares
  • Price per Share: $0.00 (Gift)
  • Nature of Transfer: Charitable Contribution / Gift
  • Ownership Post-Transaction: 14,860 shares directly held

Market & Significance Assessment

  • Trading Significance: Low. Charitable donations and gifts (Code G) are standard estate planning or philanthropic actions that do not reflect open-market sentiment or valuation perspectives.
  • Impact: Negligible dilution or supply impact on open-market liquidity.
Topics:#NBIX#NeurocrineBiosciences#InsiderTrading#Form4#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.